The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Polypharmacy Among Adults Aged 65 Years and Older in the United States: 1988–2010
Open accessAbstract
BACKGROUND: Older adults frequently have several chronic health conditions which require multiple medications. We illustrated trends in prescription medication use over 20 years in the United States, and described characteristics of older adults using multiple medications in 2009-2010. METHODS: Participants included 13,869 adults aged 65 years and older in the National Health & Nutrition Examination Survey (1988-2010). Prescription medication use was verified by medication containers. Potentially inappropriate medications were defined by the 2003 Beers Criteria. RESULTS: Between 1988 and 2010 the median number of prescription medications used among adults aged 65 and older doubled from 2 to 4, and the proportion taking ≥5 medications tripled from 12.8% (95% confidence interval: 11.1, 14.8) to 39.0% (35.8, 42.3).These increases were driven, in part, by rising use of cardioprotective and antidepressant medications. Use of potentially inappropriate medications decreased from 28.2% (25.5, 31.0) to 15.1% (13.2, 17.3) between 1988 and 2010. Higher medication use was associated with higher prevalence of functional limitation, activities of daily living limitation, and confusion/memory problems in 2009-2010, although these associations did not remain after adjustment for covariates. In multivariable models, older age, number of chronic conditions, and annual health care visits were associated with increased odds of using both 1-4 and ≥5 medications. Additionally, body mass index, higher income-poverty ratio, former smoking, and non-black non-white race were associated with use of ≥5 medications. CONCLUSIONS: Prescription medication use increased dramatically among older adults between 1988 and 2010. Contemporary older adults on multiple medications have worse health status compared with those on less medications, and appear to be a vulnerable population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“and this number had tripled from that 20 years ago [3]”
From Benefits of, Barriers to, and Needs for an Artificial Intelligence–Powered Medication Information Voice Chatbot for Older Adults: Interview Study With Geriatrics Experts (2022) · cites this paper as [3]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“One study estimated that 39% of older adults had ≥5 concurrent prescriptions”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd-Jones, D. M., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437738.63853.7a · Cited by 7,081
Fick, D. M., Cooper, J. W., Wade, W. E., Waller, J. L., Maclean, J. R., & Beers, M. H. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.22.2716 · Cited by 2,389
US trends in prevalence, awareness, treatment, and control of hypertension, 1988–2008
Egan, B. M. (2010) · JAMA · doi:10.1001/jama.2010.650 · Cited by 2,197
Clinical consequences of polypharmacy in elderly
Maher, R. L., Hanlon, J. T., & Hajjar, E. R. (2013) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2013.827660 · Cited by 1,970
Kaufman, D. W., Kelly, J. P., Rosenberg, L., Anderson, T. E., & Mitchell, A. A. (2002) · JAMA · doi:10.1001/jama.287.3.337 · Cited by 1,845
National health and nutrition examination survey: analytic guidelines, 1999-2010.
Cl, J., Paulose‐Ram, R., Ogden, C. L., Carroll, Kruszon‐Moran, D., Dohrmann, S. M., & Curtin, L. R. (2013) · PubMed · Cited by 1,522
Polypharmacy in elderly patients
Hajjar, E. R., Cafiero, A. C., & Hanlon, J. T. (2007) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2007.12.002 · Cited by 1,275
Smith, S. C., Jr. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/ahxt-ag78 · Cited by 1,037
Anderson, I. M. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00092-0 · Cited by 940
Research works printed but not linked: 4
- CDC, Patterns of Prescription Drug Use in the United States, 1988–94
- Johnson, 2013, NHANES: Analytic Guidelines, 1999–2010, Vital & Health Statistics, 2
- AMDA, Choosing Wisely: Five Things Physicians and Patients Should Question
- 10.1176/appi.ps.58.5.642 · DOI · Paper page
Cited by
Sorted by citations
By the American Geriatrics Society 2015 Beers Criteria Update Expert Panel (2015) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13702 · Cited by 2,609
Gut microbiome pattern reflects healthy ageing and predicts survival in humans
Wilmanski, T., Diener, C., Rappaport, N., Patwardhan, S., Wiedrick, J., Lapidus, J., Earls, J. C., Zimmer, A., Glusman, G., Robinson, M., et al. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00348-0 · Cited by 675
An update on the clinical consequences of polypharmacy in older adults: a narrative review
Wastesson, J. W., Morin, L., Tan, E. C. K., & Johnell, K. (2018) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2018.1546841 · Cited by 617
The silent epidemic of chronic pain in older adults
Domenichiello, A. F., & Ramsden, C. E. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.04.006 · Cited by 478
The epidemiology of polypharmacy in older adults: register-based prospective cohort study
Morin, L., Johnell, K., Laroche, M., Fastbom, J., & Wastesson, J. W. (2018) · Clinical Epidemiology · doi:10.2147/clep.s153458 · Cited by 390
Sen, A., Jetté, N., Husain, M., & Sander, J. W. A. S. (2020) · The Lancet · doi:10.1016/s0140-6736(19)33064-8 · Cited by 379
Association between polypharmacy and death: A systematic review and meta-analysis
Leelakanok, N., Holcombe, A. L., Lund, B. C., Gu, X., & Schweizer, M. L. (2017) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2017.06.002 · Cited by 355
Charoo, N. A., Ali, S. F. B., Mohamed, E. M., Kuttolamadom, M. A., Ozkan, T., Khan, M. A., & Rahman, Z. (2020) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2020.1764027 · Cited by 287
Clinical Outcomes Associated with Medication Regimen Complexity in Older People: A Systematic Review
Wimmer, B. C., Cross, A. J., Jokanovic, N., Wiese, M. D., George, J., Johnell, K., Diug, B. O., & Bell, J. S. (2016) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14682 · Cited by 231
Long-Term Use of Cardiovascular Drugs
Rosselló, X., Pocock, S., & Julian, D. G. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.07.018 · Cited by 171
Age and the aging process significantly alter the small bowel microbiome
Leite, G., Pimentel, M., Barlow, G. M., Chang, C. Y.-Y., Hosseini, A., Wang, J., Parodi, G., Sedighi, R., Rezaie, A. R., & Mathur, R. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109765 · Cited by 162
Lim, L. M., McStea, M., Chung, W. W., Azmi, N. N., Aziz, S. A. A., Alwi, S., Kamarulzaman, A., Kamaruzzaman, S. B., Chua, S. S., & Rajasuriar, R. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173466 · Cited by 128
Prevalence and trends of polypharmacy in U.S. adults, 1999–2018
Wang, X., Liu, K., Shirai, K., Tang, C., Hu, Y., Wang, Y., Hao, Y., & Dong, J.-Y. (2023) · Global Health Research and Policy · doi:10.1186/s41256-023-00311-4 · Cited by 134
Cardiovascular and skeletal muscle health with lifelong exercise
Gries, K. J., Raue, U., Perkins, R. K., Lavin, K. M., Overstreet, B. S., D’Acquisto, L. J., Graham, B., Finch, W. H., Kaminsky, L. A., Trappe, T. A., et al. (2018) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00174.2018 · Cited by 122
Wimmer, B. C., Bell, J. S., Fastbom, J., Wiese, M. D., & Johnell, K. (2015) · Annals of Pharmacotherapy · doi:10.1177/1060028015621071 · Cited by 120
Gao, L., Maidment, I., Matthews, F. E., Robinson, L., Brayne, C., & on behalf of the Medical Research Council Cognitive Function and Ageing Study (2018) · Age and Ageing · doi:10.1093/ageing/afx158 · Cited by 123
“Inactive” ingredients in oral medications
Reker, D., Blum, S. M., Steiger, C., Anger, K. E., Sommer, J. M., Fanikos, J. R., & Traverso, G. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aau6753 · Cited by 114
Substance Use among Older Adults: An Update on Prevalence, Etiology, Assessment, and Intervention
Kuerbis, A. (2019) · Gerontology · doi:10.1159/000504363 · Cited by 105
McCarthy, C., Clyne, B., Boland, F., Moriarty, F., Flood, M., Wallace, E., Smith, S. M., & for the SPPiRE Study team (2022) · PLoS Medicine · doi:10.1371/journal.pmed.1003862 · Cited by 106
Polypharmacy and patterns of prescription medication use among cancer survivors
Murphy, C. C., Fullington, H. M., Álvarez, C. A., Betts, A. C., Lee, S. J. C., Haggstrom, D. A., & Halm, E. A. (2018) · Cancer · doi:10.1002/cncr.31389 · Cited by 102
Deprescribing in older adults with polypharmacy
Hung, A., Kim, Y. H., & Pavon, J. M. (2024) · BMJ · doi:10.1136/bmj-2023-074892 · Cited by 127
McNicholl, I. R., Gandhi, M., Hare, C. B., Greene, M. L., & Pierluissi, E. (2017) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2043 · Cited by 97
Trends in multimorbidity and polypharmacy in the Flemish-Belgian population between 2000 and 2015
van den Akker, M., Vaes, B., Goderis, G., Pottelbergh, G. V., Burghgraeve, T. D., & Henrard, S. (2019) · PLoS ONE · doi:10.1371/journal.pone.0212046 · Cited by 94
A review of systemic medications that may modulate the risk of glaucoma
Wu, A. M., Khawaja, A. P., Pasquale, L. R., & Stein, J. D. (2019) · Eye · doi:10.1038/s41433-019-0603-z · Cited by 94
Non-adherence to medication regimens among older African-American adults
Bazargan, M., Smith, J. P., Yazdanshenas, H., Movassaghi, M., Martins, D., & Orum, G. (2017) · BMC Geriatrics · doi:10.1186/s12877-017-0558-5 · Cited by 90
Korhonen, M. J., Robinson, J. G., Annis, I. E., Hickson, R. P., Bell, J. S., Hartikainen, J. E. K., & Fang, G. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.07.783 · Cited by 88
The activities of drug inactive ingredients on biological targets
Pottel, J., Armstrong, D., Zou, L., Fekete, A., Huang, X., Torosyan, H., Bednarczyk, D., Whitebread, S., Bhhatarai, B., Liang, G., et al. (2020) · Science · doi:10.1126/science.aaz9906 · Cited by 91
Prevalence and determinants of polypharmacy in Switzerland: data from the CoLaus study
Castioni, J., Marques-Vidal, P. M., Abolhassani, N., Vollenweider, P., & Waeber, G. (2017) · BMC Health Services Research · doi:10.1186/s12913-017-2793-z · Cited by 84
do Nascimento, R. C. R. M., Campos, J. Á. D. B., Guerra, A. A., Gomes, I. C., Silveira, M. R., Costa, E. A., Leite, S. N., Costa, K. S., Soeiro, O. M., Guibu, I. A., et al. (2017) · Revista de Saúde Pública · doi:10.11606/s1518-8787.2017051007136 · Cited by 95
The composition of polypharmacy: A register-based study of Swedes aged 75 years and older
Wastesson, J. W., Cedazo-Mı́nguez, Á., Fastbom, J., Maioli, S., & Johnell, K. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194892 · Cited by 81
Pereira, B. C., Isreb, A., Isreb, M., Forbes, R. T., Oga, E. F., & Alhnan, M. A. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.202000236 · Cited by 78
Prevalence and factors associated with polypharmacy in the older people: 2006–2014
Carmona‐Torres, J. M., Cobo‐Cuenca, A. I., Recio‐Andrade, B., Laredo‐Aguilera, J. A., Martins, M. M., & Rodríguez‐Borrego, M. A. (2018) · Journal of Clinical Nursing · doi:10.1111/jocn.14371 · Cited by 78
Schöttker, B., Saum, K.-U., Muhlack, D. C., Hoppe, L. K., Holleczek, B., & Brenner, H. (2017) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-017-2266-7 · Cited by 77
Napping in Older Adults: a Review of Current Literature
Zhang, Z., Xiao, X., Ma, W., & Li, J. (2020) · Current Sleep Medicine Reports · doi:10.1007/s40675-020-00183-x · Cited by 75
How Chronic Is Polypharmacy in Old Age? A Longitudinal Nationwide Cohort Study
Wastesson, J. W., Morin, L., Laroche, M., & Johnell, K. (2018) · Journal of the American Geriatrics Society · doi:10.1111/jgs.15717 · Cited by 74
Al‐Azayzih, A., Alamoori, R., & Altawalbeh, S. M. (2019) · Pharmacy Practice · doi:10.18549/pharmpract.2019.2.1439 · Cited by 75
Wimmer, B. C., Bell, J. S., Fastbom, J., Wiese, M. D., & Johnell, K. (2015) · The Journals of Gerontology Series A · doi:10.1093/gerona/glv219 · Cited by 73
Gudala, M., Ross, M. E. T., Mogalla, S., Lyons, M., Ramaswamy, P., & Roberts, K. (2022) · JMIR Aging · doi:10.2196/32169 · Cited by 71
Deprescribing in the Older Patient: A Narrative Review of Challenges and Solutions
Wu, H. C., O’Donnell, L. K., Fujita, K., Masnoon, N., & Hilmer, S. N. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s253177 · Cited by 72
Trends in Polypharmacy in Japan: A Nationwide Retrospective Study
Onoue, H., Koyama, T., Zamami, Y., Hagiya, H., Tatebe, Y., Mikami, N., Shinomiya, K., Kitamura, Y., Hinotsu, S., Sendo, T., et al. (2018) · Journal of the American Geriatrics Society · doi:10.1111/jgs.15569 · Cited by 67
Kua, K. P., Saw, P. S., & Lee, S. W. H. (2019) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-019-00829-z · Cited by 69
Artificial Intelligence in Drug Treatment
Romm, E. L., & Tsigelny, I. F. (2019) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010919-023746 · Cited by 71
Factors associated with polypharmacy in elderly home‐care patients
Komiya, H., Umegaki, H., Asai, A., Kanda, S., Maeda, K., Shimojima, T., Nomura, H., & Kuzuya, M. (2017) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.13132 · Cited by 69
Drumond, N., van Riet‐Nales, D. A., Karapinar‐Çarkit, F., & Stegemann, S. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.02.029 · Cited by 65
Polypharmacy and Gait Performance in Community–dwelling Older Adults
George, C. J., & Verghese, J. (2017) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14957 · Cited by 61
Polypharmacy among the elderly
Zabihi, A., Hosseini, S., Jafarian Amiri, S., & Bijani, A. (2018) · Journal of Mid-life Health · doi:10.4103/jmh.jmh_87_17 · Cited by 60
Race and fall risk: data from the National Health and Aging Trends Study (NHATS)
Sun, D. Q., Huang, J., Varadhan, R., & Agrawal, Y. (2016) · Age and Ageing · doi:10.1093/ageing/afv173 · Cited by 60
Older Patient and Caregiver Perspectives on Medication Value and Deprescribing: A Qualitative Study
Pickering, A. N., Hamm, M., Dawdani, A., Hanlon, J. T., Thorpe, C. T., Gellad, W. F., & Radomski, T. R. (2020) · Journal of the American Geriatrics Society · doi:10.1111/jgs.16370 · Cited by 61
Polypharmacy and pattern of medication use in community‐dwelling older adults: A systematic review
Hsu, H., Chen, K., Belcastro, F. P., & Chen, Y. (2020) · Journal of Clinical Nursing · doi:10.1111/jocn.15595 · Cited by 58
Maxwell, C. J., Mondor, L., Kone, A. P., Hogan, D. B., & Wodchis, W. P. (2021) · PLoS ONE · doi:10.1371/journal.pone.0250567 · Cited by 64
Natural Language Processing as an Emerging Tool to Detect Late-Life Depression
DeSouza, D. D., Robin, J., Gumus, M., & Yeung, A. T. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.719125 · Cited by 59
Clinician knowledge and behaviors related to the 4Ms framework of Age‐Friendly Health Systems
Lesser, S., Zakharkin, S. O., Louie, C., Escobedo, M. R., Whyte, J. J., & Fulmer, T. T. (2021) · Journal of the American Geriatrics Society · doi:10.1111/jgs.17571 · Cited by 57
Wouters, H., Hilmer, S. N., Gnjidic, D., van Campen, J. P., Teichert, M., van der Meer, H. G., Schaap, L. S., Huisman, M. A., Comijs, H. C., Denig, P., et al. (2019) · The Journals of Gerontology Series A · doi:10.1093/gerona/glz019 · Cited by 60
Analysis of polypharmacy effects in older patients using Japanese Adverse Drug Event Report database
Abe, J., Umetsu, R., Uranishi, H., Suzuki, H., Nishibata, Y., Kato, Y., Ueda, N., Sasaoka, S., Hatahira, H., Motooka, Y., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0190102 · Cited by 54
Rane, P. P., Guha, S., Chatterjee, S., & Aparasu, R. R. (2016) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2016.02.012 · Cited by 56
Urfer, M., Elzi, L., Dell‐Kuster, S., & Bassetti, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166359 · Cited by 56
A Literature Review of the Potential Impact of Medication on Vitamin D Status
Wakeman, M. P. (2021) · Risk Management and Healthcare Policy · doi:10.2147/rmhp.s316897 · Cited by 58
Updates in nutrition and polypharmacy
Little, M. O. (2017) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000425 · Cited by 55
The association between polypharmacy and malnutrition(risk) in older people: A systematic review
Kok, W. E., Haverkort, E. B., Algra, Y. A., Mollema, J., Hollaar, V. R. Y., Naumann, E., de van der Schueren, M. A. E., & Jerković-Ćosić, K. (2022) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2022.03.007 · Cited by 55
Patel, T., Ivo, J., Faisal, S., McDougall, A., Carducci, J., Pritchard, S., & Chang, F. (2020) · Journal of Medical Internet Research · doi:10.2196/18073 · Cited by 49
Kristensen, A. M. D., Bovin, A., Zwisler, A., Cerquira, C., Torp-Pedersen, C. T., Bøtker, H. E., Gustafsson, I., Veien, K. T., Thomsen, K. K., Olsen, M. H., et al. (2020) · Trials · doi:10.1186/s13063-020-4214-6 · Cited by 53
Blood Pressure in Older Adults: the Importance of Frailty
Odden, M. C., Beilby, P. R., & Peralta, C. A. (2015) · Current Hypertension Reports · doi:10.1007/s11906-015-0564-y · Cited by 55
Self-citationDysphagia in Hospitalized Older Patients: Associated Factors and Nutritional Interventions
Eglseer, D., Halfens, R. J. G., Schols, J. M. G. A., & Lohrmann, C. (2017) · The journal of nutrition health & aging · doi:10.1007/s12603-017-0928-x · Cited by 56
Spotlight on the Challenges of Depression following Retirement and Opportunities for Interventions
Dang, L., Ananthasubramaniam, A., & Mezuk, B. R. (2022) · Clinical Interventions in Aging · doi:10.2147/cia.s336301 · Cited by 64
Lim, Y.-J., Kim, H.-Y., Choi, J., Lee, J. S., Ahn, A.-L., Oh, E.-J., Cho, D.-Y., & Kweon, H.-J. (2016) · Korean Journal of Family Medicine · doi:10.4082/kjfm.2016.37.6.329 · Cited by 52
Franchi, C., Marcucci, M., Mannucci, P. M., Tettamanti, M., Pasina, L., Fortino, I., Bortolotti, A., Merlino, L. G., & Nobili, A. (2015) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3938 · Cited by 50
Polypharmacy Reduction Strategies
Levy, H. B. (2017) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2017.01.007 · Cited by 56
Potentially inappropriate medication use among hypertensive older African-American adults
Bazargan, M., Smith, J. L., & King, E. (2018) · BMC Geriatrics · doi:10.1186/s12877-018-0926-9 · Cited by 49
Morin, L., Todd, A., Barclay, S. I. G., Wastesson, J. W., Fastbom, J., & Johnell, K. (2019) · Cancer · doi:10.1002/cncr.32044 · Cited by 51
Varga, Š., Alcusky, M. J., Keith, S. W., Hegarty, S., Canale, S. D., Lombardi, M., & Maio, V. (2017) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13365 · Cited by 49
Child, S. T., Nicklett, E. J., Stauber, D. B., & Ward, D. M. (2021) · American Public Health Association eBooks · doi:10.2105/9780875533162ch09 · Cited by 49
Associations of body fat and skeletal muscle with hypertension
Han, T. S., Algindan, Y., Govan, L., Hankey, C., & Lean, M. E. J. (2018) · Journal of Clinical Hypertension · doi:10.1111/jch.13456 · Cited by 48
Understanding and Preventing ( N -Nitrosodimethylamine) NDMA Contamination of Medications
White, C. M. (2019) · Annals of Pharmacotherapy · doi:10.1177/1060028019892222 · Cited by 48
A comparison of potential psychiatric drug interactions from six drug interaction database programs
Monteith, S., & Glenn, T. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.03.041 · Cited by 48
Rahman, S., Singh, K., Dhingra, S., Charan, J., Sharma, P., Islam, S., Jahan, D., Iskandar, K., Samad, N., & Haque, M. (2020) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s272908 · Cited by 49
Barriers and enablers of older adults initiating a deprescribing conversation
Ailabouni, N. J., Weir, K. R., Reeve, E., Turner, J. P., Norton, J. W., & Gray, S. L. (2021) · Patient Education and Counseling · doi:10.1016/j.pec.2021.06.021 · Cited by 55
Functional Status and Antihypertensive Therapy in Older Adults: A New Perspective on Old Data
Charlesworth, C. J., Peralta, C. A., & Odden, M. C. (2015) · American Journal of Hypertension · doi:10.1093/ajh/hpv177 · Cited by 46
Self-citationResearch Priorities for Optimizing Geriatric Pharmacotherapy: An International Consensus
Tan, E. C. K., Sluggett, J. K., Johnell, K., Onder, G., Elseviers, M. M., Morin, L., Vetrano, D. L., Wastesson, J. W., Fastbom, J., Taipale, H. T., et al. (2018) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2017.12.002 · Cited by 46
Low‐Value Proton Pump Inhibitor Prescriptions Among Older Adults at a Large Academic Health System
Mafi, J. N., May, F. P., Kahn, K. L., Chong, M. C., Corona, E., Yang, L., Mongare, M. M., Nair, V., Reynolds, C. A., Gupta, R., et al. (2019) · Journal of the American Geriatrics Society · doi:10.1111/jgs.16117 · Cited by 47
Al-Dahshan, A., Al-Kubiasi, N., Zaidan, M., Saeed, W. E., Kehyayan, V., & Bougmiza, I. M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0234386 · Cited by 46
Onder, G., Marengoni, A., Russo, P., Esposti, L. D., Fini, M., Monaco, A., Bonassi, S., Palmer, K., Marrocco, W., Pozzi, G., et al. (2016) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2015.08.009 · Cited by 44
Iqbal, A., Richardson, C. L., Iqbal, Z., O’Keefe, H., Hanratty, B., Matthews, F. E., & Todd, A. (2023) · BMC Geriatrics · doi:10.1186/s12877-023-03835-z · Cited by 44
Martín‐Pérez, M., López‐de‐Andrés, A., Hernández‐Barrera, V., Jiménez‐García, R., Jiménez‐Trujillo, I., Palacios‐Ceña, D., & Carrasco‐Garrido, P. (2016) · Revista Española de Geriatría y Gerontología · doi:10.1016/j.regg.2016.07.006 · Cited by 43
Polypharmacy in older patients at primary care units in Brazil
Gomes, M. S., Amorim, W. W., Souza, R. M., Gama, R. S., Graia, L. T., Queiroga, H. M., & Oliveira, M. G. (2019) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-018-00780-5 · Cited by 43
Bhagavathula, A. S., Tesfaye, W. H., Vidyasagar, K., & Fialová, D. (2022) · Gerontology · doi:10.1159/000521214 · Cited by 42
Wastesson, J. W., Canudas‐Romo, V., Lindahl‐Jacobsen, R., & Johnell, K. (2015) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2015.07.015 · Cited by 42
Sevilla‐Sánchez, D., Molist‐Brunet, N., Amblàs-Novellas, J., Poch, P. R., Espaulella‐Panicot, J., & Codina‐Jané, C. (2016) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-016-2136-8 · Cited by 42
Chen, E. Y. H., Sluggett, J. K., Ilomäki, J., Hilmer, S. N., Corlis, M. E., Picton, L., Dean, L., Alderman, C. P., Farinola, N., Gailer, J., et al. (2018) · Clinical Interventions in Aging · doi:10.2147/cia.s158417 · Cited by 42
Impact of Tablet Size and Shape on the Swallowability in Older Adults
Hummler, H., Stillhart, C., Meilicke, L., Grimm, M. F., Krause, E., Mannaa, M., Gollasch, M., Weitschies, W., & Page, S. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15041042 · Cited by 41
de Almeida, N. A., Reiners, A. A. O., Azevedo, R. C. D. S., da Silva, A. M. C., Cardoso, J. D. C., & de Souza, L. C. (2017) · Revista Brasileira de Geriatria e Gerontologia · doi:10.1590/1981-22562017020.160086 · Cited by 41
Overprescribed Medications for US Adults: Four Major Examples
Safer, D. J. (2019) · Journal of Clinical Medicine Research · doi:10.14740/jocmr3906 · Cited by 41
Kardas, P., Urbański, F., Lichwierowicz, A., Chudzyńska, E., Kardas, G., & Czech, M. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.655364 · Cited by 41
Aljeaidi, M. S., Haaksma, M. L., & Tan, E. C. K. (2022) · Quality of Life Research · doi:10.1007/s11136-022-03136-9 · Cited by 40
Evidence of a gabapentinoid and diuretic prescribing cascade among older adults with lower back pain
Read, S. H., Giannakeas, V., Pop, P., Bronskill, S. E., Herrmann, N., Chen, S. D. M., Luke, M. J., Wu, W., McCarthy, L. M., Austin, P. C., et al. (2021) · Journal of the American Geriatrics Society · doi:10.1111/jgs.17312 · Cited by 42
Comorbidity of patients with noncommunicable diseases in general practice. Eurasian guidelines
Drapkina, O. M., Васильевна, К. А., Калинина, А. М., Avdeev, S. N., Викторович, А. М., Алексеева, Л. И., Almazova, I. I., Andreenko, Е. Y., Antipushina, D. N., Balanova, Y. А., et al. (2024) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2024-3996 · Cited by 55
Polypharmacy in Nursing Home Residents: What Is the Way Forward?
Cherubini, A., Corsonello, A., & Lattanzio, F. (2015) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2015.07.008 · Cited by 39
An Update on Medication Use in Older Adults: a Narrative Review
Barry, H. E., & Hughes, C. M. (2021) · Current Epidemiology Reports · doi:10.1007/s40471-021-00274-5 · Cited by 38
Genetic basis of falling risk susceptibility in the UK Biobank Study
Trajanoska, K., Seppala, L. J., Medina‐Gómez, C., Hsu, Y., Zhou, S., van Schoor, N. M., de Groot, C. P. G. M., Karasik, D., Richards, J. B., Kiel, D. P., et al. (2020) · Communications Biology · doi:10.1038/s42003-020-01256-x · Cited by 41
Lee, H., Baek, Y., Kim, J. H., Liao, T., Lau, W. C. Y., Man, K. K. C., Qin, X. S., Wood, S., Ilomäki, J., Bell, J. S., et al. (2023) · Age and Ageing · doi:10.1093/ageing/afad014 · Cited by 37
Assessment and Management of Cancer Pain in Older Adults: Strategies for Success
Brant, J. M. (2018) · Asia-Pacific Journal of Oncology Nursing · doi:10.4103/apjon.apjon_11_18 · Cited by 37
Metadata
- Authors
- Charlesworth, C. J., Smit, E., Lee, D. S. H., Alramadhan, F., & Odden, M. C.
- Affiliations
- Oregon State University (US)
- Corresponding author
- Odden, Michelle C.
- Venue
- The Journals of Gerontology Series A: Biological Sciences and Medical Sciences
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-03-01
- Volume
- 70
- Issue
- 8
- Pages
- 989-995
- ISSN
- 1079-5006 (ISSN-L)
- 1758-535X
- PMC
- PMC4573668
- OpenAlex
- W2137024248
- Cited by
- 570
- References
- 29
- Citations by year
- 2026: 28 · 2025: 33 · 2024: 49 · 2023: 54 · 2022: 43 · 2021: 119 · 2020: 64 · 2019: 66 · 2018: 42 · 2017: 27 · 2016: 32 · 2015: 12
- FWCI
- 18.80
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journals of Gerontology Series A (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Heart Association
- National Institute on Aging (K01AG039387)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Health Sciences › Medicine › Epidemiology › Chronic Disease Management Strategies
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Keywords
- polypharmacy, older adults, prescription drug use, potentially inappropriate medications, Beers criteria, temporal trends, chronic disease, functional limitations, activities of daily living, cognitive impairment, cardioprotective drugs, antidepressants, health care utilization, sociodemographic factors
- MeSH terms
- Aged, Aged, 80 and over, Female, Humans, Male, Time Factors, United States, Polypharmacy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
